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Objectives/Hypothesis: To describe surgical outcomes and radiographic features of olfactory groove meningiomas
treated by excision through the subcranial approach. Special emphasis is placed on paranasal sinus and orbit involvement.
Study Design: Retrospective review of a series of patients.
Methods: Nineteen patients underwent excision of olfactory groove meningioma (OGM) via the transglabellar/subcranial
approach between December 1995 and November 2009. Nine patients had previously undergone prior resection at outside
institutions, and four had prior radiotherapy in addition to a prior excision. Transglabellar/subcranial surgical approach to
the anterior skull base was performed.
Results: Tumor histology included three World Health Organization (WHO) grade III lesions, one WHO grade II lesion,
and 15 WHO grade I lesions. Fourteen patients had evidence of extension into the paranasal sinuses, with the ethmoid sinus
being most commonly involved. Kaplan-Meier estimates of mean overall and disease-free survival were 121.45 months and
93.03 months, respectively. The mean follow-up interval was 41.0 months, and at the time of data analysis three patients had
recurrent tumors. Seven (36.8%) patients experienced a major complication in the perioperative period; there were no peri-
operative mortalities. Orbit invasion was observed in four patients, with optic nerve impingement in 11 patients. Of these,
three patients had long-term diplopia. No patients experienced worsening of preoperative visual acuity.
Conclusions: Olfactory groove meningiomas demonstrate a propensity to spread into the paranasal sinuses, particularly
in recurrent cases. Given a tendency for infiltrative recurrence along the skull base, this disease represents an important area
of collaboration between neurosurgery and otolaryngology. The subcranial approach offers excellent surgical access for exci-
sion, particularly for recurrences that involve the paranasal sinuses and optic apparatus.
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INTRODUCTION
Olfactory groove meningiomas (OGM) originate
from the anterior cranial base, commonly at the cribri-
form plate of the ethmoid bone, planum sphenoidale,
and the frontospenoidal suture. Overall, they account for
approximately 8% to 13% of the total of intracranial me-
ningiomas.1 Surgery is the preferred method of
treatment, with radiation being withheld for cases of
recurrent disease or high grade lesions.2 The extent of
primary surgery is thought to be the critical determi-
nant of long-term cure rates.3 Over the past 3 decades,
surgical trends have emerged that favor radical resec-
tion of OGM, including the dural attachment and any
involved bone. This is tempered by the delicate adjacent
anatomy, and despite efforts at complete resection the
recurrence rates of OGM over 10-year follow-up periods
have been as high as 41%.4
Caudal extension into the paranasal sinuses is
thought to be an important component in the pathogene-
sis of recurrent OGM.5 However, there is some
disagreement if sinus invasion should dictate the surgi-
cal approach, particularly in treatment of primary
disease. Some groups have postulated that bulky sino-
nasal extension in OGM is rare, and therefore is
treatable with standard craniotomies.1 Other institu-
tions have found somewhat higher rates of sinus
invasion,6 and advocate use of modified craniotomies
such as the subcranial approach for these cases.7 Orbit
invasion has also been described,8 and when present will
alter the planned approach. In the case of an OGM
involving the sinuses and/or the orbit, radical resection
entails resection of the involved portions of these bony
structures. The creation of a communicating defect
between the intracranial space and the sinonasal cavity
may increase the associated risk of postoperative cere-
brospinal fluid (CSF) leakage. Granted that entrance
into the sinuses may be necessary for radical resection,
expertise in reconstruction of skull base defects
From the Department of Otolaryngology–Head and Neck Surgery
(J.-P.P., S.L.H., E.M.L., L.J.M.), Department of Neurosurgery (S.E.S.), University
of Michigan Hospital System, Department of Radiology (S.S.G.), University
of Michigan, Ann Arbor, Michigan, U.S.A.
Editor’s Note: This Manuscript was accepted for publication May
10, 2011.
Send correspondence to Lawrence J. Marentette, MD, FACS,
Alfred Taubman Health Care Center, 1500 East Medical Center Drive,
Floor 1-Reception A, Ann Arbor, MI 48109-5312. E-mail: Marentet@med.
umich.edu
DOI: 10.1002/lary.22174
Laryngoscope 121: November 2011 Pepper et al.: Olfactory Groove Meningioma
2282
involving the sinonasal cavity is an important facet of
treatment.
We present a case series of 19 patients with OGM
treated via the subcranial approach. Special focus was
given to the sinonasal manifestation and ophthalmologic
outcomes following surgery. Our goal was to demon-
strate that a multidisciplinary approach is most effective
for treatment of OGM, particularly with respect to man-
aging tumors that invade the sinuses and abut the optic
apparatus.
MATERIALS AND METHODS
This retrospective study was based on a review of the hos-
pital and outpatient clinical records of a consecutive series of
patients who underwent excision of OGM via the subcranial/
transglabellar approach between December 1995 and November
2009. Patient and procedure data recorded for analysis included
age, gender, comorbidity, prior surgery, prior radiation, prior
chemotherapy, reconstruction type, tumor histology, and surgi-
cal margins based on final pathology. Comorbidity was defined
by the Diagnosis Related Group codes for fiscal year 2010. For
all lesions, the presence of paranasal sinus, orbit, or brain inva-
sion was determined based on review of imaging, operative
notes, and pathology reports.
The transglabellar/subcranial technique has been
described in detail previously.9 Briefly, wide exposure is
achieved through a coronal approach, with careful preservation
of a pericranial flap perfused by the supraorbital vessels
(Fig. 1). A frontal craniotomy is then made. Subperiosteal dissec-
tion is carried down inferiorly to completely free the superior
orbit and nasal root for removal of the glabellar bar. The anterior
ethmoid arteries are ligated and divided. Vertical osteotomies are
made just medial to the supraorbital notch/foramen through the
superior orbital rim. Osteotomies are then carried medially along
the anterior cranial fossa floor, staying anterior to the crista
galli. These are continued anteriorly, inferiorly, and obliquely
across the medial orbital roof and down into the nasal bones,
such that they pass anterior to the anterior lacrimal crest on
each side. Final osteotomies are created along the nasal bones
transversely, taking care to leave approximately 3 mm of nasal
bone distally to support the upper lateral cartilages. A sharply
curved osteotome is used to separate the bony nasal septum from
the supraorbital bar. Although small modifications are made
depending on tumor extent, the approach consistently provides
generous in-line access to the anterior cranial base while mini-
mizing or eliminating the need for frontal lobe retraction. The
neurosurgery team performs the extirpation, usually with micro-
dissection of tumor adjacent to the optic nerves, optic chiasm, or
frontal lobe. Reconstruction is performed with a pericranial flap
or with a free flap for previously irradiated patients.
Complications were classified as perioperative if they
occurred within 30 days of the surgical procedure. These were
divided into major and minor subcategories. Major complica-
tions were predefined as those associated with mortality,
Fig. 1. (A) Intraoperative images from the subcranial approach. Bicoronal approach with raising of a robust pericranial flap pedicled on the
supraorbital vessels. (B) Following bifrontal craniotomy, osteotomies are made separating the medial aspect of frontal bar with the width
adjusted based on the tumor extent. (C) Following resection of the specimen, the operative field shows the generous in-line access
afforded.
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reoperation, procedural intervention (i.e., delayed lumbar
drain), and/or permanent morbidity. Minor complications were
those that were not associated with any permanent treatment
or permanent morbidity. Additional postoperative data included
surgical margins based on final pathology reported as Simpson
resection grade. Assessment of visual acuity was performed in
the outpatient clinic and documented by the neurosurgery, oto-
laryngology, or ophthalmology services.
The Kaplan-Meier method was used to estimate overall and
disease-free survival. Survival estimates were generated on SPSS
for Windows, version 11.01 (SPSS, Inc., Chicago, IL). The study
was approved by our university’s institutional review board.
RESULTS
Clinical presentation, treatment history, preopera-
tive radiographic tumor size, and paranasal sinus
involvement is listed for each patient in Table I. There
was a high rate of paranasal sinus involvement in this
series, with 14 of 19 patients (73.7%) having tumors
that extended into the paranasal sinuses, with the eth-
moid sinus being the most frequently involved subsite.
There were nine recurrent tumors in the series, and
prior therapy included surgery and/or radiation. There
were three malignant tumors (World Health Organiza-
tion [WHO] grade III). A representative preoperative
magnetic resonance imaging sequence is presented in
Figure 2. This demonstrates a recurrent tumor with an
extensive and infiltrative pattern of recurrence along
the skull base, involving the ethmoid sinuses as well as
the orbit. During the perioperative period, the most com-
mon intracranial complication was delayed CSF
rhinorrhea (Table II). Ten patients of the 19 experienced
a perioperative complication, with seven patients
(36.8%) experiencing a major complication. There were
no perioperative mortalities.
The Kaplan-Meier method was used to estimate overall
survival (Fig. 3) as well as disease-free survival (Fig. 4). The
estimated mean for overall survival was 121.45 months
(95% confidence interval [CI], 93.23-149.66) and the esti-
mated mean for disease-free survival was 93.03 months
(95% CI, 60.88-125.18). Table III highlights additional long-
term clinical outcomes. Notably, of the 19 total patients in
this series, 15 had preoperative tumor involvement of either
the orbit or the optic nerve. Of these, three patients had
long-term postoperative diplopia. One patient suffered an
abducens nerve palsy after surgery. The other two patients
had extensive orbital spread of meningioma that required
dissection of tumor near the attachment of the extraocular
muscles. No patient experienced permanent decline in vis-
ual acuity compared to preoperative visual exam.
TABLE I.
Patient Presentation and Treatment History.
ID Age, yr/ Gender Prior Treatment Clinical Presentation Lesion Size, cm
Sinus
Involvement
Histology
(WHO)*
Resection
Grade†
1 68/male None Hypophthalmos 4.64.21.0 E, F III 1
2 67/ male None Headache, diplopia 2.32.41.0 E I 2
3 56/ male None Confusion, lethargy 7.04.03.2 E, F, S II 1
4 52/ male None Headache, dysgeusia 3.22.82.5 E I 2
5 62/female None Altered mental status 5.35.63.6 E I 3
6 63/ female None Headache, anosmia 5.06.05.0 None I 4
7 60/ male Surgery, Radiation Headache, vision loss 3.52.3 4.6 cm E, S I 4
8 36/M Surgery, Radiation Nasal obstruction, hyposmia NA‡ E, NC III 1
9 19/male Surgery Decreased visual acuity 4.54.85.2 E, S, NC I 1
10 15/male None Generalized tonic-clonic
seizures, headache
7.06.75.5 F I 4
11 47/ female Surgery Blindness, nasal
obstruction
6.36.15.6 E, S, NC I 3
12 53/ female Surgery, Radiation Memory loss, sleepiness,
visual acuity
4.54.64.5 None III 1
13 51/ male Surgery, Radiation Headache, disinhibition NA‡ E, S I 1
14 67/ female Surgery Epistaxis, nasal obstruction 6.03.03.0 E, F, M, S, NC I 1
15 62/ male None Dementia, hyposmia,
papilledema
6.06.05.0 None I 1
16 46/ female None Forehead mass 4.5 maximum diameter F I 1
17 37/ female None Headache NA‡ None I 1
18 51/ female Surgery Headache, memory loss 552.9 None I 4
19 57/male Surgery Decreased visual acuity 3.53.5 E, S I 4
Lesion size is measured in three dimensions by magnetic resonance imaging (MRI) or computed tomography scan; MRI is preferred if both available.
Sinus involvement is based on preoperative imaging, confirmed via operative report.
*Histology is graded via World Health Organization (WHO) for meningiomas (I, II, or III).
†Simpson grading system used for resection as follows: grade 1 ¼ complete resection, including underlying dura and bone; grade 2 ¼ complete resec-
tion with coagulation of underlying dura; grade 3 ¼ complete without resection or coagulation of dura; grade 4 ¼ subtotal resection.
‡Preoperative MRI not located in radiology archives.
E ¼ ethmoid; F ¼ frontal; S ¼ sphenoid; NA ¼ not available; NC ¼ nasal cavity; M ¼ maxillary.
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DISCUSSION
The caudal extension of OGM into the paranasal
sinuses is a matter of some debate, both in terms of its
frequency and its significance for surgical planning.
One of the earliest estimates of this frequency stated
that approximately 15% of OGM invade the ethmoid
sinuses.10 Nakamura et al. recently published a large
series on OGM; they noted a 19.5% rate of paranasal
sinus involvement.1 The authors qualify this by stating
that it is rare for OGM to have a predominant burden of
disease in the sinuses. On the other hand, another
recent series reported sinonasal extension in 26.3% of
cases of OGM.6 Several authors have highlighted the
importance of paranasal sinus extension in the pathoge-
nesis of OGM, particularly in recurrent cases.5,6 The
high rate of sinonasal involvement in this series likely
reflects both the large number of recurrent tumors, as
well as the influence of a referral bias to our multidisci-
plinary skull base team.
Meningioma in the sinonasal cavity usually repre-
sents secondary extension of the tumor through the
anterior skull base. Primary extradural meningiomas
are rare.2 OGMs have a predilection for bony invasion of
the cribriform plate and planum sphenoidale. The hyper-
ostosis that often characterizes these tumors is thought
Fig. 2. (A) Axial magnetic resonance
imaging (MRI) sections demonstrate
the typical character of skull base
meningiomas. T2 weighted imaging
(T2) shows a moderately low signal
mass along the left frontal bone
inner table causing contour distor-
tion of the left frontal lobe. Fluid-
attenuated inversion-recovery imag-
ing (FLAIR) shows that this lesion is
nonedemogenic (short arrow). Non-
contrast T1 weighted imaging (T1)
shows the brain-like signal character
of the mass as well as the nearby
bony reaction, in this portion, bone
induction (‘‘bone’’ with thin arrow).
T1 weighted imaging after intrave-
nous (IV) contrast (GAD) shows the
marked, quite homogeneous, patho-
logic contrast enhancement of the
mass and its long dural tail (long
arrow). (B) Coronal T1-weighted MRI
sections after IV contrast demon-
strate the highly invasive character
of this mass with bulky peridural in-
tracranial spread (arrow), direct
intraorbital extension (O), and direct
paranasal sinus extension (S).
TABLE II.
Intracranial Complications and Mortalities Occurring in the
Perioperative Period (First 30 Days Postoperative).
Complications No. (%)
Mortality 0
CSF leak 3 (15.8)
Meningitis 1 (5.3)
Cerebral edema 3 (15.8)
Tension pneumocephalus 1 (5.3)
Intracranial hematoma 2 (10.5)
Cerebrovascular accident 1 (5.3)
Additional complications not listed include deep vein thrombosis (2),
arrhythmia (2), and pulmonary infection (3).
CSF ¼ cerebrospinal fluid.
Fig. 3. Kaplan-Meier method for estimation of overall survival for
patients treated via the subcranial approach for resection of olfac-
tory groove meningioma.
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to be a byproduct of tumor microinvasion rather than a
reactive inflammatory process from the adjacent tu-
mor.11 It is thought that insufficient resection of
unrecognized bone invasion may lead to higher rates of
recurrence.5 Reoperation is certainly more challenging,
and often entails delicate decompression of the optic
nerve in an area with poor tissue planes.6
Recurrence rates have been reported as high as
41% in large series with 10-year follow-up.4 Lower-grade
resections have been found to be a significant predictor
of recurrence.3 Surgical trends have therefore shifted in
favor of more aggressive resection.5,6 The complexity of
the anterior skull base poses obvious challenges to
achieving radical resection. Given that higher rates of
bony invasion have been demonstrated in recurrent
tumors,12 excision of involved bone will by definition cre-
ate a large cranial floor defect that freely communicates
with the sinonasal cavity. In our opinion, this argues for
multidisciplinary collaboration between otolaryngology
and neurosurgery to allow for generous exposure, exci-
sion, and reconstruction of complex defects to minimize
morbidity.
As there is no consensus regarding the best
approach to OGM resection, debate over the merits and
drawbacks of different surgical approaches to tumors of
the anterior cranial base is ongoing. Comparisons of the
indications, advantages, and disadvantages of various
approaches have been detailed elsewhere.6,13,14 Tables IV
and V provide a broad comparison of surgical approaches,
tumor characteristics, and outcomes of several OGM
series described in the literature. The present series has a
relatively high number of recurrent tumors, a high fre-
quency of paranasal sinus invasion, and also includes
atypical and anaplastic histologic subtypes.
With specific regard to visual outcomes, Gazzeri
et al. report impressive results and low morbidity using
the bifrontal approach.15 The large average tumor size
and longstanding nature of the preoperative visual defi-
cits make these successes yet more impressive. In that
series, all tumors were WHO grade I, arose de novo, and
only one (2.8%) demonstrated paranasal sinus invasion.
Tumors with more extensive inferior spread may not be
as amenable to bifrontal resection. Paranasal sinus
extension was noted in 30.4% of tumors undergoing
bifrontal resection in the Nakamura series, and 22.9% of
those in the Spektor series.1,6 In both series, all mortal-
ities occurred in patients who underwent a bifrontal
approach. Nakamura et al. ascribe these mortalities to
brain edema consequent to the bifrontal approach and
the large tumors resected with this approach.
The subcranial approach has several advantages in
the treatment of OGM that merit discussion. It offers
excellent access to the frontal, ethmoid, and sphenoid
sinuses should tumor extend to these locations. Access
to the orbit is generous as well, and ligation of the ante-
rior ethmoid artery will, in theory, decrease bleeding
during tumor excision as this is thought to be a key irri-
gating vessel for OGM.2 The long-term vision results
Fig. 4. Kaplan-Meier method for estimation of disease-free survival
for patients treated via the subcranial approach for resection of ol-
factory groove meningioma.
TABLE III.
Long-Term Outcomes Following Subcranial Approach for Resection of Olfactory Groove Meningioma.
Variable Total
Number of recurrences 3 (15.8%)
Mean overall survival 121.45 (95% CI, 93.23-149.66)
Mean disease-free survival, mo 93.03 (95% CI, 60.88-125.18)
Subsequent revision surgery (not for recurrence) 5 (26.3%)
Preoperative optic nerve, optic chiasm, or orbit impingement 15 (78.9%)
Postoperative decline of visual acuity (via documented exam)* 0
Postoperative prolonged diplopia 3 (15.8%)
Postoperative nasolacrimal duct obstruction 1 (5.3%)
Karnovsky preoperative score (mean)† 73.0
Karnovsky postoperative score (mean)† 77.5
There were three recurrences over the period of study (1995–2009). Eight patients subsequently underwent revision surgery not for recurrence. These
included cranioplasty, free flap revision, and dacrocystorhinostomy.
*Visual acuity exams performed prior to adjuvant radiotherapy.
†Karnovsky data was available for eight of the 19 patients in this series.
CI ¼ confidence interval.
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presented above suggest that this approach offers an
excellent route to safely address intraorbital disease while
also enabling wide exposure for effective microdissection
of tumor off of the optic nerve and chiasm. Three patients
had postoperative diplopia that was worsened after sur-
gery. Of these, one patient suffered an abducens nerve
injury during removal of the tumor and two patients had
extensive intraorbital disease that necessitated intraorbi-
tal dissection along the attachment areas of the
extraocular muscles. One patient had preoperative blind-
ness in the affected eye, which did not improve following
tumor excision. Overall, preservation of preoperative vis-
ual acuity was excellent, which is a credit to effective
microdissection following good exposure.
The overall survival in this series is expectedly
high given that OGM may exhibit an indolent growth
pattern. During the period of study, three tumors dem-
onstrated clinical or radiographic evidence of recurrence.
It should be noted, however, that this series includes one
atypical (WHO grade II) and three malignant (WHO
grade III) lesions. In addition, nine tumors were recur-
rences, with four of these having undergone prior
radiotherapy in addition to prior surgery. Some recent
case series have excluded high grade lesions,1 and there-
fore one must bear this in mind when comparing short-
and long-term outcomes. Furthermore, the high rate of
paranasal sinus extension reflects tumor spread that
was fairly extensive. In our opinion, this attests to the
effectiveness of the subcranial approach in these cases.
One of the drawbacks of the subcranial approach
that has been discussed in the context of OGM is that it
is a time-consuming technique in relation to other com-
monly performed craniotomies (pterional, subfrontal,
and bifrontal).6 This is a valid criticism, as our average
case duration was just under 13 hours. However, many
of these cases required extensive microdissection along
the optic apparatus, and this would be necessary regard-
less of the approach selected. Another concern with the
subcranial approach is that removal of the frontal (gla-
bellar) bar may result in long-term contour defects. Of
the 19 cases of OGM treated, five patients underwent
follow-up surgery that involved a revision of the initial
reconstruction. Two patients underwent free flap revi-
sions (one was performed on the harvest site), one
patient underwent a cranioplasty for a contour defect,
and two patients underwent washout procedures after
developing osteomyelitis of the bone flap. The patients
with bone flap osteomyelitis all had undergone adjuvant
radiotherapy for either recurrent or high-grade (WHO
III) disease. Osteomyelitis ensued after completion of the
adjuvant treatment. Whether or not this is a widespread
problem in patients undergoing radiotherapy following
open skull base surgery is a question that merits study
in a larger series.
TABLE IV.
Samples Characteristics of Multiple Series of Olfactory Groove Meningioma.
Series Surgical Approach n Histology (%)*
Visual
Symptoms (%)
Sinus
Involvement (%) Notes
Tsikoudas and
Martin-Hirsch, 199929
Bifrontal, unilateral
subfrontal
13 NA 5 (38.4) NA
Turazzi et al., 199930 Pterional 37 NA 16 (43.2) 1 (2.7%)
Hentschel and
DeMonte, 200324
Bifrontal/biorbital 13 NA 6 (46.2) 6 (46.2%)
Obeid and Al-Mefty,
20035
Bifrontal, unilateral
subfrontal
15 I (100) 12(80.0) 10 (66.7) Six (33.3%) recurrent
tumors; sinus involvement
in all recurrent and four
(44.4%) de novo tumors
Spektor et al., 20056 Bifrontal, unilateral
subfrontal, pterional,
fronto-orbital,
subcranial
80 I (97.5), II (2.5) 22 (27.5) 21 (26.3) Nine (11.3%) recurrent tumors
Bassiouni et al., 200731 Bifrontal, pterional,
unilateral frontal,
supraorbital
56 I (98.2), II (1.8) 12 (21.4) Simpson grade 1 resection
achieved almost exclusively
by unilateral frontal approach
Nakamura et al., 20071 Bifrontal, unilateral
subfrontal,
pterional
82 I (100) 20 (24.4) 16 (19.5) Sinus involvement in 30.4%
of bifrontal cases, 5.8%
of unilateral subfrontal cases
Gazzeri et al., 200815 Bifrontal 36 I (100) 20 (55.5) 1 (2.8) Size represents equivalent,
not maximum, diameter;
very large tumors
Chen et al., 200932 Bifrontal, unilateral-
subfrontal,
inter-hemispheric,
pterional,
bi-fronto-orbital
35 See note 9 (25.7) 0 (0) Four (11.4%) recurrent
tumors; two resected
tumors recurred with
WHO grade II histology
El-Bahy, 200914 Unilateral subfrontal 18 I 5 (27.8) 3 (16.7) Sinus involvement noted
to be non-extensive
Present series Subcranial 19 I (78.9); II (5.3);
III (15.8)
5 (26.3) 14 (73.7) Nine (47.4%) recurrent
tumors
*World Health Organization grading system for meningiomas (I, II, or III).
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A third potential drawback of the subcranial
approach is that the rates of CSF leak may be higher
given the wide exposure of the cranial base. Indeed,
given the trend toward radical resection of OGM, the
rate of postoperative CSF leak is an important outcome
for analysis in any series. The CSF leak rate reported
here (15.8%) is similar to comparable series, which
employed a variety of standard craniotomies.6
Over the past decade, the applications of skull base
endoscopic surgery have steadily expanded.16 Possible
technical advantages include early tumor devasculariza-
tion, direct tumor access without brain retraction or
exposure, and minimal manipulation of neurovascular
structures including the optic nerve.17–20 Secondary
advantages relate primarily to the fact that the tech-
nique is minimally invasive, with the potential for
shorter hospital stays, decreased postoperative pain, and
improved cosmesis.20–22 In a recent study, Gardner et al.
describe a series of 35 anterior cranial base meningio-
mas removed by the endoscopic endonasal approach.17
Complete resection was achieved in 83% of cases
intended for complete resection and in 67% of all OGM
cases. Impressively, they report improved visual out-
comes in all patients presenting with visual symptoms.
The authors attribute this success to the endoscopic
technique, as it affords both minimal manipulation of
the optic nerve as well as microdissection of tumor off a
compressed, ischemic optic nerve that is displaced supe-
riorly, as is generally the case with tuburculum sellae
meningiomas.17 Indeed, endoscopic surgery has yielded
excellent visual outcomes in tuburculum sellae meningi-
omas.23 OGMs, however, tend to displace the optic nerve
inferiorly and posteriorly.6,13,24 Gardner et al. note that
in such cases visual improvement is likely the result of
simple decompression, even with incomplete resection.
The most commonly cited criticism of the endoscopic
approach is the high rate of CSF leak. The previously
discussed series reports a CSF leak rate of 40%.17
Incomplete visualization of the floor of the anterior and
cranial fossa and of minor dural defects may contribute
TABLE V.
Outcomes of Multiple Series of Olfactory Groove Meningioma.
Series
Complete
Resection* (%)
Recurrence
(%)
Mortality
(%)
CSF
Leak (%)
Mean
Follow-Up Notes
Tsikoudas and
Martin-Hirsch, 199929
13 (100) 3 (23.1) 2 (15.4) 3 (23.1) NA One patient with worsened
visual acuity
Turazzi et al., 199930 37 (100) 0 (0) 1 (3.7) 0 (0) 4 yr Sixteen (100%) improved
visual function
Hentschel and
DeMonte, 200324
11 (84.6) 0 (0) 0 (0) 0 (0) 2 yr Five (83%) improved
visual function
Obeid and Al-Mefty, 20035 72 (90.0) 0 (0) 0 (0) 3 (20) 5.9 yr One patient with worsened
visual acuity
Spektor et al., 20056 13 (86.7) 2 (2.5) 1 (1.3) 10 (12.5) 3.7 yr
Bassouni et al., 200731 56 (100) 5 (8.9) 3 (5.4) 3 (5.4) 5.6 yr Ten (83%) had improved
visual function; all CSF
leaks and recurrences
occurred in cases
undergoing bifrontal
approach (large, bilateral
tumors were selected for
bifrontal resection)
Nakamura et al., 20071 76 (92.7) 4 (4.9) 4 (4.9) 3 (3.7) 5.3 yr All mortalities had bifrontal
approach. Higher
recurrence rate in tumors
with sinus involvement;
11 (55.0%) had improved
visual function
Gazzeri et al., 200815 31 (86.1) 2 (5.5) 1 (2.8) 2 (5.5) 9.3 yr Average duration of visual
symptoms was 27.4
months; eight (40.0%)
had improved visual
function; one patient
with worsened vision
postoperatively
Chen et al., 200932 29 (82.9) 4 (11.4) 0 (0) 4 (11.4) 5.3 yr
El Bahy et al., 200914 14 (77.8) 0 (0) 1 (5.6) 3 (16.7) 2.6 yr Four (80%) had improved
visual outcomes; ACA
encasement and tumor
size correlate with
complications
Present series 12 (63.2) 3 (15.8) 0 (0) 3 (15.8) 3.4 yr Three patients with
postoperative diplopia;
none with worsened
visual acuity
*Complete resection defined as Simpson grade 1 or 2.
CSF ¼ cerebrospinal fluid; NA ¼ not available; ACA ¼ anterior cerebral artery.
Laryngoscope 121: November 2011 Pepper et al.: Olfactory Groove Meningioma
2288
to this high leak rate.25 It is important to note that in
the Gardner series, no patients experiencing CSF leak
required reoperation, and there were no reported cases
of bacterial meningitis. Furthermore, recent innovations
in pedicled nasoseptal flap reconstruction have
decreased CSF leak rates significantly.26,27
A comparative analysis of the merits of endoscopic
OGM removal versus the subcranial approach is some-
what handicapped by the inclusion criteria of each
study. The possible contraindications to endoscopic extir-
pation listed in prior studies are numerous: large tumor
size, tumor consistency, encasement of vascular struc-
tures, lateral extension, lateral dural attachment, brain
invasion, frontal sinus extension, and the presence of
long dural tails.14,18,20 At the heart of the matter is the
notion that recurrence rates may prove to be higher
with endoscopic approaches, as all suspicious underlying
bone should be resected (Simpson grade I resection),
which is presumably facilitated by open exposure.25 This
claim, though intuitive, is not definitively substantiated
by available data. Long-term follow-up data following
endoscopic resection of OGM will help to more precisely
define the indications for endoscopic removal. It remains
to be seen if recurrent tumors, tumors with more aggres-
sive histology, and lesions involving the optic apparatus
are all addressed effectively via endoscopic approaches.
This data will hopefully be useful for such future com-
parisons. Currently, proponents of the endoscopic
approach admit that it is indicated in carefully selected
patients, and caution that the learning curve is
steep.17,28 Despite the restrictive indications for endo-
scopic resection of OGM, it remains an evolving field
that holds great promise for the future.
CONCLUSION
OGM is a skull base neoplasm with significant rates of
bony infiltration and subsequent spread to the paranasal
sinuses. The subcranial approach offers excellent access for
resection of OGM, particularly in cases where tumor
extends to the paranasal sinus and orbit. Despite a signifi-
cant number of recurrent or aggressive histologic subtypes,
the surgical outcomes over the period of follow-up were com-
parable to other recent series. Vision preservation was a
notable and important benefit. As a whole, this underscores
the value of the otolaryngologist–head and neck surgeon in
the multidisciplinary management of these tumors.
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